Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
NTrans Technologies BV logo — Natural delivery to unlock the full potential of cell and ge...

NTrans Technologies BV

Natural delivery to unlock the full potential of cell and gene therapies

Founded 2015 The Netherlands The Netherlands 8 employees

General Information

Company Name NTrans Technologies BV
Founded Year 2015
Location The Netherlands The Netherlands +1
Employees 8
Social

Get notified when NTrans Technologies BV moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About NTrans Technologies BV

Imagine a world where we conquer cancer and genetic diseases. At NTrans Technologies, we solve key challenges in cell and gene therapy: Delivering life-changing therapies to the right cells and tissues. We leverage nature’s own mechanisms for cellular uptake to ensure efficient and safe therapeutic delivery. Welcome to the next frontier of medicine. Our proprietary platform is GMP-ready and sets a new standard in cell and gene therapy. We use a non-viral delivery system to harness macropinocytosis - a natural cellular uptake process - for precise and secure delivery of gene-editing technologies. The mission of NTrans Technologies is to become the leading non-viral delivery platform in cell and gene therapy. Please contact us at: [email protected]

No funding data available for NTrans Technologies BV yet.

Get notified when NTrans Technologies BV raises funding

NTrans Technologies BV Alternatives & Competitors

NTrans Technologies BV vs
Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc. United States

A Member of the Roche Group

Acquired
81 employees
Biopharma, Biotechnology
NTrans Technologies BV vs
SIRION BIOTECH GmbH (Revvity Gene Delivery)
SIRION BIOTECH GmbH (Revvity Gene Delivery) Germany

Any Gene to Any Cell

Series Unknown
25 employees
Biotechnology, Pharmaceutical
NTrans Technologies BV vs
Basilard BioTech, Inc.
Basilard BioTech, Inc. United States

Nanomechanical Gene Delivery to Transform the Engineering of Cell Based Therapies

Seed
5 employees
Biopharma, Biotechnology

FAQ About NTrans Technologies BV

Natural delivery to unlock the full potential of cell and gene therapies
NTrans Technologies BV was founded in 2015.
NTrans Technologies BV is headquartered in The Netherlands.
NTrans Technologies BV has approximately 8 employees.
Top alternatives and competitors to NTrans Technologies BV include Poseida Therapeutics, Inc., SIRION BIOTECH GmbH (Revvity Gene Delivery), Basilard BioTech, Inc., Avectas , Bionavigen. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NTrans Technologies BV and Poseida Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors NTrans Technologies BV and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy